期刊文献+

脑膜瘤细胞增殖活性与术后复发的关系 被引量:4

Relationship between Proliferative Activity and Postoperative Recurrence of Meningioma
下载PDF
导出
摘要 目的:探讨脑膜瘤的增殖活性与术后复发的关系。方法:采用免疫组化法检测增殖细胞核抗原(PCNA)在98例脑膜瘤(其中复发38例)中的表达,同时进行流式细胞术(FCM)检测,分析脑膜瘤64例(其中复发组34例,非复发组30例)术后复发与DNA含量的关系。结果:脑膜瘤术后复发组与非复发组PCNA标记指数(PCNA LI)分别为11.65±12.49与1.54±2.46,两者比较差异有显著性(P<0.01),说明脑膜瘤术后复发与PCNA的表达呈显著正相关。同时复发性脑膜瘤的异倍体率(52.3%)、DNA指数DI(1.17±0.12)和增殖指数PI(26.74±10.89)均显著高于非复发组异倍体率(6.7%),DI(1.01±0.11)和PI(14.06±7.68)(P<0.01)。结论:通过PCNA检测及流式细胞术(FCM)DNA含量分析可较准确地判定肿瘤的增殖潜能,以用于指导临床治疗和判断预后。 Objective To study the relationship between the proliferative activity and postoperative recurrence of meningioma. Methods The expression of PCNA protein was examined in 98 cases by immunohistochemical technique and the content of DNA in 64 cases were detected by flow cytometry FCM. Reasults The PCNA labelling index of recurrence and non-recurrence groups were 11.65±12.49 and 1.54±2.46 respectively with significant difference between these two groups P<0.01. The heteroploid rate 52.3% DNA index 1.17±0.12 and proliferative index 26.74±10.89 of recurrent meningiomas were obviously higher than the data in non-recurrent tumors 1.01±0.11 14.06±7.68 and 14.06±7.68 respectively P<0.01. Conclusion The detection of PCNA protein and analysis of DNA content by FCM could be used to judge the proliferative activity for instructing the clinical therapy and predicting the prognosis of meningioma.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2001年第7期495-497,共3页 Chinese Journal of Clinical Oncology
基金 天津市卫生局科研基金资助
关键词 脑膜瘤 复发 PCNA 检测 流式细胞术 FCM 细胞增殖 Meningioma Recurrence PCNA FCM
  • 相关文献

参考文献3

共引文献16

同被引文献21

  • 1Hsu DW, Efird JT, Hedley-Whyte ET. MIB-1 (Ki-67) index and transforming growth factor-alpha (TG Falpha) immunoreactivity are significant prognostic predictors for meningiomas[J]. Neuropathol Appl Neurobiol, 1998, 24 (6): 441~452.
  • 2Perry A, Stafford SL, Scheithauer BW, et al. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas [J]. Cancer, 1998, 82 (11): 2262~2269.
  • 3Ho DMT, Hsu CY, Ting LT, et al . Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma [J]. Cancer, 2002, 94 (5): 1538~1547.
  • 4Korshunov A, Shishkina L, Golanov A. DNA topoisomerase Ⅱ-(alpha) and cyclin A immunoexpression in meningiomas and its prognostic significance: An analysis of 263 cases [J]. Arch Pathol Lab Med, 2002, 126 (9): 1079~1086.
  • 5Meixensberger J, Janka M, Zellner A, et al . Prognostic significance of nuclear DNA content in human meningiomas: a prospective study [J]. Acta Neurochir Suppl (Wien), 1996, 65: 70~72.
  • 6Abramovich CM, Prayson RA. Apoptotic activity and bcl-2 immunoreactivity in meningiomas. Association with grade and outcome [J]. Am J Clin Pathol, 2000, 114(1): 84~92.
  • 7Konstantinidou A, Korkolopoulou P, Patsouris E, et al . Apoptosis detected with monoclonal antibody to singlestranded DNA is a predictor of recurrence in intracranial meningiomas [J]. J Neurooncol, 2001, 55 (1): 1~9.
  • 8Kamei Y, Watanabe M, Nakayama T, et al . Prognostic si gnificance of p53 and p21WAF1/CIP1 immunoreactivity and tumor micronecrosis for recurrence of meningiomas [J].J Neurooncol, 2000, 46 (3): 205~213.
  • 9Karamitopoulou E, Perentes E, Tolnay M, et al. Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas [J]. Hum Pathol, 1998, 29 (2): 140~145.
  • 10Sano T, Asai A, Mishima K, et al . Telomerase activity in 144 brain tumors [J]. Br J Cancer, 1998, 77 (10): 1633~ 1637.

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部